Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-27
2009-12-01
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S234500, C514S303000, C546S118000, C544S061000, C544S118000
Reexamination Certificate
active
07625890
ABSTRACT:
Invented are novel 1H-imidazo[4,5-c]pyridin-2-yl compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
REFERENCES:
patent: 4336257 (1982-06-01), Baldwin
patent: 5958950 (1999-09-01), Padia et al.
patent: 5972980 (1999-10-01), Cornicelli et al.
patent: 6001866 (1999-12-01), Cornicelli et al.
patent: 6130333 (2000-10-01), Huang et al.
patent: 6211367 (2001-04-01), Cavalla et al.
patent: 6399621 (2002-06-01), Dusza et al.
patent: 6770666 (2004-08-01), Hashimoto et al.
patent: 6897208 (2005-05-01), Edwards et al.
patent: 7041687 (2006-05-01), Binch et al.
patent: 7112600 (2006-09-01), Hashimoto et al.
patent: 2003/0220365 (2003-11-01), Stewart et al.
patent: 2004/0034037 (2004-02-01), Harbeson et al.
patent: 2005/0153978 (2005-07-01), Alberti et al.
patent: 2005/0176760 (2005-08-01), Cezanne et al.
patent: 2005/0182075 (2005-08-01), Yuan
patent: 2005/0197328 (2005-09-01), Bailey et al.
patent: 2006/0074102 (2006-04-01), Cusack et al.
patent: 2007/0004771 (2007-01-01), Lee et al.
patent: 2007/0043061 (2007-02-01), Eberle et al.
patent: 2007/0123561 (2007-05-01), Lee et al.
patent: 2007/0149561 (2007-06-01), Dhanak et al.
patent: 2008/0076763 (2008-03-01), Heerding et al.
patent: 1702919 (2004-12-01), None
patent: WO01/13882 (2001-03-01), None
patent: WO02/32896 (2002-04-01), None
patent: WO2005/011700 (2005-02-01), None
patent: WO2005/037197 (2005-04-01), None
patent: WO2005/037198 (2005-04-01), None
patent: WO2005/046678 (2005-05-01), None
patent: WO2005/082890 (2005-09-01), None
patent: WO2005/085227 (2005-09-01), None
patent: WO2006/113837 (2006-10-01), None
patent: WO2007/058852 (2007-05-01), None
patent: WO2007/058879 (2007-05-01), None
patent: WO2007/076423 (2007-07-01), None
patent: WO2008/058383 (2008-05-01), None
patent: WO2008/058603 (2008-05-01), None
patent: WO2008/098104 (2008-08-01), None
patent: WO2008/098105 (2008-08-01), None
Vippgunta et. al., Advanced Drug Delivery Reviews, 2001, 48, 3-26.
STN structure search, downloaded Feb. 1, 2008, pp. 29-31.
Anderson, et al., J. Org. Chem., 2003, vol. 68, pp. 9563-9573.
Abraham, Current Opinion of Imm., 1996, vol. 8, pp. 412-416.
Ashby, Current Opinion in Lipidology, 1998, vol. 9, No. 2, pp. 99-102.
Bolen, et al., Annu. Rev. Immunol., 1997, vol. 15, pp. 371-404 and table of contents.
Brodt, et al., Biochemical Pharm., 2000, vol. 60, pp. 1101-1107.
Bruns, et al., Cancer Research, 2000, vol. 60, pp. 2926-2935.
Canman, et al., Oncogene, 1998, vol. 17, pp. 3301-3308.
Chen, et al., Cancer Research, 1998, vol. 58, pp. 1965-1971.
Choi, et al., Cell Transplantation, 2002, vol. 11, pp. 359-368.
Forastiere, Seminars in Oncology, 1993, vol. 20. No. 4, Suppl. 3, pp. 56-60.
Holmes, et al., J. of the Nat'l Cancer Inst., 1991, vol. 83, No. 24, pp. 1797-1805.
Jackson, Int. J. Biochem. Cell Biol., 1997, vol. 29, No. 7, pp. 935-938.
Kath, Exp. Opin. Ther. Patents, 2000, vol. 10, No. 6, pp. 803-818.
Kearns, et al., Seminars in Oncology, 1995, vol. 22, No. 3, suppl. 6, pp. 16-23.
Kerr and Workman, New Molecular Targets for Cancer Chemotherapy, 1993, CRC Press, Cancer Research Campaign Beatson Laboratories, University of Glasgow, UK. Table of Contents, pp. 67-79.
Kelley, et al., J. Med. Chem., 1995, vol. 38, pp. 4131-4134.
Kingston, et al., Studies in Organic Chemsitry, 1986, vol. 26., pp. 219-235.
Kitada,e t al., Antisense Research & Dev., 1994, vol. 4, pp. 71-79.
Kumar, The J. of Biol. Chem., 1981, vol. 256, No. 20, pp. 10435-10441.
Lackey, et al., Bioorg. & Med. Chem. Letters, 2000, vol. 10, pp. 223-226.
Larock, Comprehensive Organic Transformations, Published 1989, Book Cover & Table of Contents.
Markman, The Yale J. of Biol. & Medicine, 1991, vol. 64, pp. 583-590.
Martinez-Lacaci, et al., Int. J. Cancer, 2000, Vol. 88, pp. 44-52.
Massague, et al., Cancer Surveys, 1996, ol. 27, pp. 41-64.
McGuire, et al., Annals of Internal Medicine, 1989, vol. 111, pp. 273-279.
Mitsunobu, Synthesis, The Use of Diethyl Azadicarboxylate and Triphenylphosphine, 1981, pp. 1-28.
Oliff, Biochemica et Biophysica Acta, 1999, vol. 1423, pp. C19-C30.
Reilly, et al., Cancer Research, 2000, vol. 60, pp. 3569-3576.
Rosania, et al., Exp. Opin. Ther. Patents, 2000, vol. 10, No. 2, pp. 215-230.
Sanchez, et al., J. Hetercyclic Chem., 1993, vol. 30, pp. 855-859.
Schreiber, et al., Science, 1986, vol. 232, pp. 1250-1253.
Scharosky, et al., J. Biomed Sci, 2000, vol. 7, pp. 292-298.
Schiff, et al., Nature, 1979, vol. 277, pp. 665-667.
Schiff, et al., Proc. Natl. Acad. Sci., 1980, vol. 77, No. 3, pp. 1561-1565.
Shawver, et al., DDT, 1997, vol. 2, No. 2, pp. 51-63.
Sinha, et al., J. of Hematotherapy & Stem Cel Research, 1999, vol. 8, pp. 465-480.
Smithgall, et al., J. of Pharm. & Toxicol. Methods, 1995, vol. 34, pp. 125-132.
Wani, et al., Chem. & Life Sciences Lab, NC, 1971, pp. 2325-2327.
Waters, et al., J. of Clinical Oncology, 2000, vol. 18, No. 9, pp. 1812-1823.
Yamamoto, et al., J. Biochem, 1999, vol. 126, pp. 799-803.
Yen, et al., Oncogene, 2000, vol. 19, pp. 3460-3469.
Zhong, et al., Cancer Research, 2000, vol. 60, pp. 1541-1545.
Nawwar, et al., Anales De Quimica, 1993, vol. 89, No. 3, pp. 375-378.
Li, et al., Current Topics in Med. Chem., 2002 vol. 2, pp. 939-971.
Olesen, et al., J. Med. Chem., 2003, vol. 46, pp. 3333-3341.
Bamford, et al., Bioorganic & Med. Chem. Letters, vol. 15, pp. 3407-3411.
Barraclough, et al., Archiv der Pharmazie, 1990, vol. 323, pp. 507-512.
Yutilov, et al., Khimiya Geterosiklicheskikh Soedinenii, 1989, vol. 7, pp. 940-947. (org. & translation).
PCT/US2006/043518 filed Nov. 9, 2006.
PCT/US2006/043617 filed Nov. 9, 2006.
PCT/US2006/062453 filed Nov. 9, 2006.
Wadler, et.al.,Proc. Am. Soc. Clin. Oncol., (20), 2001, abstract.
Hassner & Stumer,Organic Syntheses Based on Name Reactions and Unnamed Reactions, Oxford, New York: Pergamon; Table of Contents (1994).
Clark Tammy J.
Heerding Dirk A.
Leber Jack Dale
Safonov Igor
Dustman Wayne J.
Gimmi Edward R.
Kinzig Charles M.
Moore Susanna
SmithKline Beecham Corp.
LandOfFree
Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4056007